← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2006Last known activity
Jan 2, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 6 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT07257029Lead sponsorPhase 2Jan 2, 2026
- NCT07257029OfficialPhase 2Jan 2, 2026
- NCT07257029Sponsor investigatorPhase 2Jan 2, 2026
- NCT03782480Reponsible party - principal investigatorPhase 3Mar 2, 2019
- NCT03782480Lead sponsorPhase 3Mar 2, 2019
- NCT03189238Lead sponsorPhase 2Jun 28, 2017
- NCT03045172Lead sponsorN/ANov 1, 2016
- NCT03045172Overall official - principal investigatorN/ANov 1, 2016
- NCT02794363Lead sponsorN/AMay 1, 2014
- NCT00393263Lead sponsorPhase 2Oct 1, 2006
- NCT00393263Reponsible party - principal investigatorPhase 2Oct 1, 2006
- NCT00393263Overall official - principal investigatorPhase 2Oct 1, 2006
Details
- Founded
- Washington D.C., US
- Last known activity
- Jan 2, 2026